Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,485 total articles
Cloudflare's recent Agent Cloud and developer tooling rollouts are starting to show up in the stock: improving technical momentum, healthy free cash flow and consistent top-line growth. Valuation is rich on P/S but several near-term catalysts could re-rate the multiple if 2H adoption of AI agents and security demand accelerates. This trade idea tak…
Palo Alto Networks is positioned to capture outsized cybersecurity spend tied to AI deployments. The market is still debating whether AI will compress software multiples; we think AI increases security budgets and validates Palo Alto's platform approach. The technicals are supportive and the company produces strong free cash flow, presenting a favo…
SAFRAN SA ORD (SAFRF) gapped and closed materially lower, leaving the stock trading well below its 10/20/50-day averages even as short interest has exploded. The technical picture is oversold but fragile; a disciplined long with a tight stop and a target near the 50-day SMA offers a defined risk/reward to capture a mean-reversion move or a short-co…
BlackBerry has moved from speculative pivot to evidence-driven turnaround. Recent QNX deals with Nvidia and Leapmotor, GAAP profitability, and improving free cash flow create a tradable setup. Valuation still demands delivery, but risk/reward favors a tactical long over the next 45 trading days.
Datadog's observability platform is becoming an essential control plane for enterprises wrestling with AI systems. Adoption of AI-aware monitoring is accelerating revenue growth and FCF generation, while valuation has reset from last year's peak. We recommend a long trade with clear entry, stop and target and a 180-trading-day horizon to capture pr…
NEOS Enhanced Income 1-3 Month T-Bill ETF (CSHI) trades like cash but delivers a positive spread versus standalone T-bills through a systematic large-cap put-spread futures strategy. At a $49.81 price and $1.09B market cap, CSHI offers a low-volatility way to pick up incremental yield while keeping principal exposure tightly anchored to short-term …
Kinder Morgan combines a durable, contract-heavy pipeline business with improving cash flow and a steady dividend. With Q1 momentum, a multi-year project backlog and a 3.7%+ yield, KMI is an actionable long trade for income-focused investors over the next 180 trading days. Entry at $31.75, stop at $29.00, target $35.00.
Alibaba is no longer just a marketplace. The company’s push into AI infrastructure, embodied robotics and enterprise cloud services is starting to show in both product announcements and improving price action. With a market cap of $320.5B, a modest P/E of 25.2 and bullish technical momentum, BABA looks positioned for a measured comeback. This trade…
AMD is trading like a winner of the AI infrastructure era: strong top-line momentum across processors and accelerators, clean balance sheet, and sizable free cash flow, but the stock is richly valued and technically overbought. This trade idea lays out a disciplined long position into earnings with defined risk, a $349 entry, $320 stop and $400 tar…
ServiceNow dropped sharply after guidance and gross-margin noise on 04/23/2026. The market reaction discounted high-quality recurring revenue and $4.58B of free cash flow. With a $94.3B market cap, a PE of 53x, and technicals showing oversold-but-stabilizing action, we view the sell-off as overdone and actionable for a mid-term swing trade to $115 …
Dell is trading near its 52-week high after a sustained run. Behind the move is a structural shift: inference workloads are proliferating outside GPU-dominated training clusters, and that plays to Dell's strengths in CPU-based servers, storage and systems integration. With a sizable server backlog, positive free cash flow, and reasonable valuation …
Palo Alto Networks (PANW) trades richly, but its subscription-driven revenue, $3.57B in free cash flow, rising AI-security momentum and technical strength make a measured long position attractive over the next 180 trading days. This trade plan gives a precise entry at $178.55, a stop at $165.00 and a target of $230.00 with a medium risk posture.
Skilled-labor constraints are pushing companies toward consolidation, strategic partnerships and capital-market solutions. Evercore (EVR) is positioned to monetize that shift via its advisory-first model, strong margins and healthy cash flow. We lay out an actionable long trade with entry, stop and target, plus catalysts and risks.
Oncolytics (ONCY) is trading near $1.05 with a market cap of roughly $115M. Recent regulatory momentum for pelareorep - including Fast Track designation in KRAS-mutant colorectal cancer - and an orderly capital structure set up the company to re-rate if management executes on registrational trials or FDA alignment. This trade idea outlines a long e…
Intuit has been punished on AI angst and sector-wide weakness, but the fundamentals remain intact: $6.9B free cash flow, double-digit ROE, modest leverage and a $109.5B market cap. We upgrade our rating and lay out a clear risk-managed trade with entry at $395.95, stop at $360.00 and a $520.00 target over a 180-trading-day horizon.
Broadcom combines custom AI silicon, entrenched data-center networking franchises, and cash-flow-rich software assets. At today’s levels the stock is richly valued, but momentum, a $29B free cash flow run-rate, and customer traction make a pullback buyable for a 180-trading-day trade targeting further multiple expansion and topping-cycle demand.
Vaalco Energy is showing real operational progress in 2026 — recent Etame development production, the return of the Baobab FPSO, and the sale of non-core Canadian assets have improved cash-flow geometry and refocused the asset-base. At $6.14, shares trade with modest multiples (EV/EBITDA ~4.6) and a supportive quarterly dividend, presenting an acti…
Broadcom's mix of custom AI silicon and infrastructure software positions it to capture outsized data-center spending. The stock is extended but backed by strong cash flow and profitability. This trade idea targets a mid-term rebound while respecting high multiples and near-term technical overbought conditions.
Chewy trades like a recovering growth retailer with defensive demand traits: a $10.8B market cap, a high recurring revenue mix from Autoship, and improving cash flow. At $26.14 the risk/reward favors a long trade targeting $35 over the next 180 trading days, while protecting capital with a $23 stop.
Aurora Cannabis (ACB) trades at a sub-$200M market cap with a P/B near 0.54 and meaningful short interest. Regulatory moves in the U.S., ongoing industry premiumization, and the company’s downsized cost base create an asymmetric risk/reward for a mid-term trade. I outline an entry at $3.385, a stop at $2.90 and a $5.50 target tied to a ~60-65% upsi…
XOP offers a way to buy a diversified, equal-weighted basket of U.S. exploration & production names that have already recovered from 52-week lows but remain below recent highs. With a $3.23B market cap, a 2.07% yield and technicals near neutral, this ETF is a pragmatic swing trade: entry $168.00, stop $160.00, target $190.00 over a mid-term horizon…
Eli Lilly (LLY) has the balance sheet, cash flow, and a leading GLP-1 franchise to recover from recent volatility. The stock is trading off materially from its highs and the technicals are soft, so the trade is a tactical mid-term long: enter at $880.00, stop at $820.00, target $980.00 over ~45 trading days. Keep position size disciplined — this is…
Freeport-McMoRan (FCX) dipped after a Grasberg delay and guidance cut, creating a tactical long opportunity. With market cap around $87.7B, EV/EBITDA near 10.7 and free cash flow of ~$1.12B, the company can ride a copper rebound if supply tightness persists. Trade plan: enter $61.05, target $70.00, stop $57.00 - mid-term (45 trading days) swing.
UnitedHealth (UNH) delivered a convincing Q1, raised full-year guidance and reinstated buybacks, signaling a recovery. Fundamentals have improved - medical cost trends, Optum momentum and $2B in buybacks matter - but technicals are stretched (RSI ~82) and valuation is full. This trade proposes a measured long on a pullback with clear stop and targe…
Medpace remains a high-quality contract research organization with durable free cash flow and elevated margins. Recent weakness has brought the stock down toward technical support and improved entry economics, but multiple securities class actions and book-to-bill questions introduce headline risk. I downgrade my conviction but maintain a Buy trade…
